BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 30747081)

  • 1. Cancer Therapy Based on Smart Drug Delivery with Advanced Nanoparticles.
    Kong X; Liu Y; Huang X; Huang S; Gao F; Rong P; Zhang S; Zhang K; Zeng W
    Anticancer Agents Med Chem; 2019; 19(6):720-730. PubMed ID: 30747081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smart Drug-Delivery Systems for Cancer Nanotherapy.
    Sanchez-Moreno P; Ortega-Vinuesa JL; Peula-Garcia JM; Marchal JA; Boulaiz H
    Curr Drug Targets; 2018 Feb; 19(4):339-359. PubMed ID: 27231107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in "smart" delivery systems for extended drug release in cancer therapy.
    Kalaydina RV; Bajwa K; Qorri B; Decarlo A; Szewczuk MR
    Int J Nanomedicine; 2018; 13():4727-4745. PubMed ID: 30154657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Internal and External Triggering Mechanism of "Smart" Nanoparticle-Based DDSs in Targeted Tumor Therapy.
    Qian XL; Li J; Wei R; Lin H; Xiong LX
    Curr Pharm Des; 2018; 24(15):1639-1651. PubMed ID: 29745324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances in pH-Sensitive Polymeric Nanoparticles for Smart Drug Delivery in Cancer Therapy.
    Lim EK; Chung BH; Chung SJ
    Curr Drug Targets; 2018 Feb; 19(4):300-317. PubMed ID: 27262486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer Nanotheranostics: A Nanomedicinal Approach for Cancer Therapy and Diagnosis.
    Kundu P; Singh D; Singh A; Sahoo SK
    Anticancer Agents Med Chem; 2020; 20(11):1288-1299. PubMed ID: 31429694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prominent Role of Protein-Based Delivery Systems on the Development of Cancer Treatment.
    Kouchakzadeh H; Abbas Shojaosadati S
    Curr Pharm Des; 2016; 22(22):3455-65. PubMed ID: 26845324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functionalized Graphene Oxide for Chemotherapeutic Drug Delivery and Cancer Treatment: A Promising Material in Nanomedicine.
    Sharma H; Mondal S
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox Potential and ROS-Mediated Nanomedicines for Improving Cancer Therapy.
    Glass SB; Gonzalez-Fajardo L; Beringhs AO; Lu X
    Antioxid Redox Signal; 2019 Feb; 30(5):747-761. PubMed ID: 28990403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Smart' nanoparticles as drug delivery systems for applications in tumor therapy.
    Fang Z; Wan LY; Chu LY; Zhang YQ; Wu JF
    Expert Opin Drug Deliv; 2015; 12(12):1943-53. PubMed ID: 26193970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smart multifunctional drug delivery towards anticancer therapy harmonized in mesoporous nanoparticles.
    Baek S; Singh RK; Khanal D; Patel KD; Lee EJ; Leong KW; Chrzanowski W; Kim HW
    Nanoscale; 2015 Sep; 7(34):14191-216. PubMed ID: 26260245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smart Cancer Cell Targeting Imaging and Drug Delivery System by Systematically Engineering Periodic Mesoporous Organosilica Nanoparticles.
    Lu N; Tian Y; Tian W; Huang P; Liu Y; Tang Y; Wang C; Wang S; Su Y; Zhang Y; Pan J; Teng Z; Lu G
    ACS Appl Mater Interfaces; 2016 Feb; 8(5):2985-93. PubMed ID: 26767305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Strategies in Cancer Nanomedicine.
    Tong R; Kohane DS
    Annu Rev Pharmacol Toxicol; 2016; 56():41-57. PubMed ID: 26514197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimuli-responsive polymeric nanoparticles for nanomedicine.
    Crucho CI
    ChemMedChem; 2015 Jan; 10(1):24-38. PubMed ID: 25319803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect.
    Acharya S; Sahoo SK
    Adv Drug Deliv Rev; 2011 Mar; 63(3):170-83. PubMed ID: 20965219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
    Du JZ; Li HJ; Wang J
    Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicine for Treatment of Lung Cancer.
    Hussain S
    Adv Exp Med Biol; 2016; 890():137-47. PubMed ID: 26703803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnology-based immunotherapies to combat cancer metastasis.
    Zhao Y; Bilal M; Qindeel M; Khan MI; Dhama K; Iqbal HMN
    Mol Biol Rep; 2021 Sep; 48(9):6563-6580. PubMed ID: 34424444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.